Financials Positive

2026-05-30 18:58

The Board of Directors of Jeena Sikho Lifecare Limited approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, with an unmodified audit opinion. The board also recommended a final dividend of Rs. 4.50/- per equity share for the financial year 2025-26, subject to shareholder approval. Additionally, M/s Forvis Mazars LLP was re-appointed as the Internal Auditor for FY 2026-27.

Financials Positive

2026-05-30 18:41

Jeena Sikho Lifecare Limited reported robust Q4 FY26 consolidated financial performance with Revenue from Operations at ₹215.55 Cr compared to ₹139.25 Cr in Q4 FY25, marking a 54.79% YoY increase. EBITDA grew by 70.24% YoY to ₹77.92 Cr from ₹45.77 Cr, with EBITDA Margin expanding by 328 bps to 36.15% from 32.87%. Net Profit (PAT) surged by 77.89% YoY to ₹45.08 Cr from ₹25.34 Cr. The Board recommended a final dividend of Rs. 4.50 per equity share for the financial year 2025-26.

Financials Positive

2026-05-30 18:41

The Board of Directors of Jeena Sikho Lifecare Limited approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, which received an unmodified audit opinion. The board recommended a final dividend of Rs. 4.50/- per equity share for the financial year 2025-26, subject to shareholder approval. M/s Forvis Mazars LLP was also re-appointed as the Internal Auditor for FY 2026-27.

Financials Positive

2026-05-30 18:41

Jeena Sikho Lifecare Limited's Board of Directors approved the Audited Standalone and Consolidated Financial Results for the quarter and financial year ended March 31, 2026, with an unmodified audit opinion. The Board also recommended a final dividend of Rs. 4.50/- per equity share for FY 2025-26, subject to shareholder approval. Additionally, M/s Forvis Mazars LLP was re-appointed as the Internal Auditor for FY 2026-27.

Business Update Neutral

2026-05-27 18:02

Jeena Sikho Lifecare Limited announced an Earnings Conference Call for Investors and Analysts for Q4 FY26 audited financial results. The call is scheduled for Tuesday, 02nd June, 2026, at 01:30 P.M. IST and will feature Mr. Manish Grover (Managing Director) and Mr. Nanak Chand (Chief Financial Officer).

Business Update Positive

2026-05-25 19:20

Jeena Sikho Lifecare Limited announced on May 25, 2026, the publication of multiple case studies and reports authored by its associated medical professionals in international journals. These publications demonstrate the Company's ongoing commitment to Ayurvedic research and evidence-based clinical practice, covering various health conditions like chronic kidney disease, gastrointestinal stromal tumor, and female infertility.

Business Update Positive

2026-05-09 18:45

Jeena Sikho Lifecare Limited's Board approved the sale of approximately 48 Bigha of non-operational land in Patiala, Punjab, to Tresco Realty Group LLP for ₹24,00,00,000 (Twenty-Four Crores). The company stated the sale will have no impact on its business operations as the land was not used for business activities, and the transaction is not a related party transaction, effectively freeing up capital from a non-core asset.

Business Update Positive

2026-05-08 17:56

Jeena Sikho Lifecare Limited's Board approved the sale of approximately 48 Bigha of non-operational land in Punjab to Tresco Realty Group LLP for ₹24,00,00,000/- (Twenty-Four Crores Only). The company stated that the sale will not impact its core business operations as the land was non-operational.

Routine Neutral

2026-05-04 20:29

New Filing detected. See link for details.

Business Update Positive

2026-05-04 19:18

Jeena Sikho Lifecare Limited announced on May 4, 2026, the publication of seven case studies and two case reports authored by its associated medical professionals, including the Managing Director, in the 'Journal of Applied Science and Education (JASE)'. These publications demonstrate the Company's commitment to Ayurvedic research and evidence-based clinical practice, covering conditions like chronic kidney disease, sciatica, osteoarthritis, and liver cirrhosis.

Business Update Positive

2026-04-15 17:24

Jeena Sikho Lifecare Limited's Noida Hospital received NABH Accreditation (AH-2026-0451), valid until March 9, 2029. This signifies adherence to nationally recognized quality healthcare standards, enhancing patient safety and operational excellence.

Business Update Positive

2026-04-14 23:30

Jeena Sikho Lifecare Limited signed a Strategic MOU with Sat Kartar Life Limited on April 14, 2026. This collaboration aims to integrate patient acquisition with Jeena Sikho's healthcare infrastructure for enhanced efficiency and patient outcomes, and develop Ayurveda hospitals. It includes a 15% revenue share for SKL.

Routine Neutral

2026-03-23 13:40

Jeena Sikho Lifecare Limited announced the closure of the trading window for Designated Persons and their immediate relatives from April 01, 2026, until 48 hours after the declaration of Audited Financial Results for the Quarter and Financial Year ended March 31, 2026.

Business Update Positive

2026-03-23 12:31

Jeena Sikho Lifecare Limited announced the publication of three academic case studies/reports on Ayurvedic management of chronic liver disease, kidney disease, and prostatomegaly in the "International Journal of Advanced Research (IJAR)" on March 23, 2026, showcasing its commitment to Ayurvedic research and evidence-based clinical practice.

Business Update Neutral

2026-03-17 16:00

Jeena Sikho Lifecare Limited announced an Investor/Analyst Meet on March 23, 2026, at Trident, BKC, Mumbai. Managing Director Mr. Manish Grover and Dr. Ish Sharma will meet institutional investors in a physical group meeting organized by DAM capital.

Governance Neutral

2026-03-09 12:34

Jeena Sikho Lifecare Limited's Board on March 09, 2026, approved amendments to its Code of Fair Disclosure and Insider Trading Policy as per SEBI PIT Regulations, 2015. The updated code will be available on the company website.

Business Update Neutral

2026-03-06 17:31

Jeena Sikho Lifecare Limited announced its Managing Director, CFO, and Dr. Ish Sharma will participate virtually in the Arihant Capital Bharat Connect Conference- Rising Stars 2026 on March 11, 2026. No unpublished price sensitive information will be shared.

Business Update Positive

2026-02-23 14:37

Jeena Sikho Lifecare Limited announced the publication of five (5) case studies and one (1) case report authored by their medical professionals in the "International Journal of Advanced Research (IJAR)" and the "Journal of Ayurveda and Integrated Medical Sciences (JAIMS)", showcasing their commitment to Ayurvedic research and evidence-based clinical practice.

Business Update Positive

2026-02-19 13:21

Jeena Sikho Lifecare Limited has received the National Accreditation Board for Hospitals & Healthcare Providers (NABH) Certificate of Accreditation for its Dehradun Hospital, specifically for Panchakarma services. This accreditation signifies adherence to nationally recognized standards for quality healthcare delivery and operational excellence, valid until January 2029.

Business Update Positive

2026-02-16 18:46

Jeena Sikho Lifecare Limited announced establishing a new 150-bed hospital unit in Ahmedabad, Gujarat, with an estimated investment of ₹1.5 Crore. The unit is expected to commence operations within 6 months, strengthening the company's presence and healthcare services.

Financials Positive

2026-02-13 16:38

Consolidated Revenue ₹221.7Cr vs ₹115.47Cr (▲92% YoY), EBITDA ₹100.8Cr vs ₹29.65Cr (▲240% YoY), PAT ₹66.7Cr vs ₹13.21Cr (▲405% YoY). EBITDA Margin 45% vs 25.68% (▲1932bps).

Financials Positive

2026-02-10 12:25

Consolidated Revenue ₹221.68Cr vs ₹115.69Cr (▲92% YoY), EBITDA ₹100.72Cr vs ₹29.61Cr (▲240% YoY), PAT ₹66.60Cr vs ₹13.21Cr (▲404% YoY). EBITDA Margin 45.44% vs 25.59% (▲1985bps).

Business Update Neutral

2026-02-09 19:25

Jeena Sikho Lifecare Limited submitted the audio recording of its Earnings Conference Call for Q3 FY 2025-26, held on February 9, 2026. The recording, which discusses the financial results for the quarter ended December 31, 2025, is available on the company's website.

Financials Neutral

2026-02-08 14:26

Jeena Sikho Lifecare Limited submitted its Investor Presentation for Q3 FY26 financial performance on February 08, 2026. This presentation, enclosed with the filing, was discussed in a conference call on February 04, 2026, and is being used for investor meetings scheduled for February 09, 2026.

Financials Positive

2026-02-07 19:06

Consolidated Revenue ₹221.68Cr vs ₹115.69Cr (▲91.6% YoY), EBITDA ₹103.29Cr vs ₹30.00Cr (▲244.3% YoY), PAT ₹66.60Cr vs ₹13.21Cr (▲404.1% YoY). EBITDA Margin 46.6% vs 25.9% (▲2066bps).

Financials Neutral

2026-02-07 18:56

The Board of Directors of Jeena Sikho Lifecare Limited approved the unaudited standalone and consolidated financial results for the quarter and nine months ended 31st December 2025 at its meeting held on February 7, 2026. The actual financial figures are not provided in this filing.

Business Update Positive

2026-01-22 13:18

Jeena Sikho Lifecare Limited announced the publication of a case report in 'Ayush Journal of Integrative Oncology' on Jan 22, 2026. The report details a post-mastectomy breast cancer survivor's one-year disease-free resolution via Ayurvedic interventions, showcasing the company's commitment to evidence-based clinical practices.

Business Update Negative

2026-01-21 19:23

CRITICAL RED FLAG DETECTED

Board approved an unsecured loan of AED 7.53 million (8.5% interest, 5-year tenure) to its wholly-owned subsidiary, Jeena Sikho International LLC, for business needs. The Board also noted and paid fines imposed by NSE/BSE for non-compliance with SEBI regulations, implementing corrective measures.

Ownership Positive

2026-01-16 17:12

Jeena Sikho Lifecare Limited announced the acquisition of a 51% equity stake in Back to Roots Ayurveda by Dr. Shyam LLC, Abu Dhabi, UAE for 1,530,000 Dirhams. The acquisition aims to strengthen their Ayurveda and wellness segment.

Routine Neutral

2026-01-13 13:37

Jeena Sikho Lifecare Limited entered into a Procurement Agreement with Theryco Healthcare Solutions on January 3rd, 2026, to list and sell products on Amazon. The agreement is not a related party transaction.

Routine Neutral

2026-01-12 14:35

Jeena Sikho Lifecare Limited published case studies and a research article in European and International Journals on Ayurvedic management of Type 2 Diabetes and Chronic Kidney Disease (dated Jan 12, 2026).

Routine Neutral

2026-01-07 16:14

Jeena Sikho Lifecare published 9 case studies and reports on Ayurvedic treatments in various journals | Dated January 7, 2026.

JSLL

Jeena Sikho Lifecare Limited

Filing History

Unlock Full History